In this regard, the correlation between PD-L1 and CD73 has been related to cancer prognosis [63,64], and blocking CD73 and PD-L1 has been shown to promote the T-cell response [65,66]; hence, these results offer a promising therapeutic strategy for cancer. This evidence concerns the gene NT5E and cancer.